Contrasting Agape ATP (NASDAQ:ATPC) and Sharps Technology (NASDAQ:STSS)

Institutional and Insider Ownership

0.0% of Agape ATP shares are owned by institutional investors. Comparatively, 17.2% of Sharps Technology shares are owned by institutional investors. 9.7% of Agape ATP shares are owned by company insiders. Comparatively, 0.2% of Sharps Technology shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Earnings & Valuation

This table compares Agape ATP and Sharps Technology”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agape ATP	$1.32 million	51.90	-$2.47 million	($0.60)	-2.28
Sharps Technology	N/A	N/A	-$9.30 million	($1,881.9301)	0.00

Agape ATP has higher revenue and earnings than Sharps Technology. Agape ATP is trading at a lower price-to-earnings ratio than Sharps Technology, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Agape ATP and Sharps Technology’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Agape ATP	-191.34%	-30.95%	-27.00%
Sharps Technology	N/A	-98.77%	-53.85%

Volatility & Risk

Agape ATP has a beta of -0.97, meaning that its share price is 197% less volatile than the S&P 500. Comparatively, Sharps Technology has a beta of 2.15, meaning that its share price is 115% more volatile than the S&P 500.

Summary

Agape ATP beats Sharps Technology on 6 of the 10 factors compared between the two stocks.

About Agape ATP

Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement. It also provides BEAUNIQUE brand products comprising Mito+, an antioxidant drink for cellular, immune, metabolic, brain, and skin health; and Trim+, which inhibits the activities of carbohydrates digestive enzymes that result in a reduction of the breakdown and absorption of sugars. In addition, the company offers energy masks, including N°1 Med-Hydration, N°2 Med-Whitening, and N°3 Med-Firming, as well as hyaluronic acid serum and mousse facial cleanser under ÉNERGÉTIQUE brand; and soy protein isolate powder, and an antioxidant under Livo5 brand name. Further, it sells health and wellness products; and promotes wellness and wellbeing lifestyle through online editorials, programs, events, and campaigns, as well as provides health therapies. The company was incorporated in 2016 and is headquartered in Kuala Lumpur, Malaysia.

About Sharps Technology

Sharps Technology, Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc. was incorporated in 2017 and is based in Melville, New York.